324 related articles for article (PubMed ID: 2783259)
21. Point mutations in the Moloney murine leukemia virus enhancer identify a lymphoid-specific viral core motif and 1,3-phorbol myristate acetate-inducible element.
Speck NA; Renjifo B; Hopkins N
J Virol; 1990 Feb; 64(2):543-50. PubMed ID: 2104942
[TBL] [Abstract][Full Text] [Related]
22. A transcriptional enhancer with specificity for erythroid cells is located in the long terminal repeat of the Friend murine leukemia virus.
Bösze Z; Thiesen HJ; Charnay P
EMBO J; 1986 Jul; 5(7):1615-23. PubMed ID: 3462001
[TBL] [Abstract][Full Text] [Related]
23. Genetic basis of disease specificity of nondefective Friend murine leukemia virus.
Hopkins N
Ann N Y Acad Sci; 1989; 567():14-25. PubMed ID: 2679314
[No Abstract] [Full Text] [Related]
24. Comparison of the transcriptional properties of the Friend and Moloney retrovirus long terminal repeats: importance of tandem duplications and of the core enhancer sequence.
Clark SP; Kaufhold R; Chan A; Mak TW
Virology; 1985 Jul; 144(2):481-94. PubMed ID: 4060594
[TBL] [Abstract][Full Text] [Related]
25. Important role of the long terminal repeat of the helper Moloney murine leukemia virus in Abelson virus-induced lymphoma.
Savard P; DesGroseillers L; Rassart E; Poirier Y; Jolicoeur P
J Virol; 1987 Oct; 61(10):3266-75. PubMed ID: 3041046
[TBL] [Abstract][Full Text] [Related]
26. Sequences in the U5-gag-pol region influence early and late pathogenic effects of Friend and Moloney murine leukemia viruses.
Sitbon M; Ellerbrok H; Pozo F; Nishio J; Hayes SF; Evans LH; Chesebro B
J Virol; 1990 May; 64(5):2135-40. PubMed ID: 2182908
[TBL] [Abstract][Full Text] [Related]
27. The reduced virulence of the thymotropic Moloney murine leukemia virus derivative MoMuLV-TB is mapped to 11 mutations within the U3 region of the long terminal repeat.
Yuen PH; Szurek PF
J Virol; 1989 Feb; 63(2):471-80. PubMed ID: 2783465
[TBL] [Abstract][Full Text] [Related]
28. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells.
Baum C; Hegewisch-Becker S; Eckert HG; Stocking C; Ostertag W
J Virol; 1995 Dec; 69(12):7541-7. PubMed ID: 7494260
[TBL] [Abstract][Full Text] [Related]
29. Escape from in vivo restriction of Moloney mink cell focus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations.
Brightman BK; Farmer C; Fan H
J Virol; 1993 Dec; 67(12):7140-8. PubMed ID: 8230436
[TBL] [Abstract][Full Text] [Related]
30. Tissue-specific replication of Friend and Moloney murine leukemia viruses in infected mice.
Evans LH; Morrey JD
J Virol; 1987 May; 61(5):1350-7. PubMed ID: 3033265
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a protein that binds multiple sequences in mammalian type C retrovirus enhancers.
Sun W; O'Connell M; Speck NA
J Virol; 1993 Apr; 67(4):1976-86. PubMed ID: 8445719
[TBL] [Abstract][Full Text] [Related]
32. Molecular characterization of a neuropathogenic and nonerythroleukemogenic variant of Friend murine leukemia virus PVC-211.
Masuda M; Remington MP; Hoffman PM; Ruscetti SK
J Virol; 1992 May; 66(5):2798-806. PubMed ID: 1560524
[TBL] [Abstract][Full Text] [Related]
33. The envelope gene and long terminal repeat sequences contribute to the pathogenic phenotype of helper-independent Friend viruses.
Oliff A; Signorelli K; Collins L
J Virol; 1984 Sep; 51(3):788-94. PubMed ID: 6088801
[TBL] [Abstract][Full Text] [Related]
34. Regions of the Moloney murine leukemia virus genome specifically related to induction of promonocytic tumors.
Wolff L; Koller R
J Virol; 1990 Jan; 64(1):155-60. PubMed ID: 2403439
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the env gene and long terminal repeat of molecularly cloned Friend mink cell focus-inducing virus DNA.
Adachi A; Sakai K; Kitamura N; Nakanishi S; Niwa O; Matsuyama M; Ishimoto A
J Virol; 1984 Jun; 50(3):813-21. PubMed ID: 6328011
[TBL] [Abstract][Full Text] [Related]
36. Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro.
Fan H; Mittal S; Chute H; Chao E; Pattengale PK
J Virol; 1986 Oct; 60(1):204-14. PubMed ID: 3747027
[TBL] [Abstract][Full Text] [Related]
37. Nucleotide sequence of the envelope gene of Friend murine leukemia virus.
Koch W; Hunsmann G; Friedrich R
J Virol; 1983 Jan; 45(1):1-9. PubMed ID: 6296423
[TBL] [Abstract][Full Text] [Related]
38. Contributions to transcriptional activity and to viral leukemogenicity made by sequences within and downstream of the MCF13 murine leukemia virus enhancer.
Tupper JC; Chen H; Hays EF; Bristol GC; Yoshimura FK
J Virol; 1992 Dec; 66(12):7080-8. PubMed ID: 1331510
[TBL] [Abstract][Full Text] [Related]
39. Differential disease restriction of Moloney and Friend murine leukemia viruses by the mouse Rmcf gene is governed by the viral long terminal repeat.
Brightman BK; Li QX; Trepp DJ; Fan H
J Exp Med; 1991 Aug; 174(2):389-96. PubMed ID: 1856627
[TBL] [Abstract][Full Text] [Related]
40. A pancreas specificity results from the combination of polyomavirus and Moloney murine leukemia virus enhancer.
Rochford R; Campbell BA; Villarreal LP
Proc Natl Acad Sci U S A; 1987 Jan; 84(2):449-53. PubMed ID: 3025873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
